Phytotherapy in Benign Prostatic Hyperplasia

    January 2018 in “ Elsevier eBooks ”
    Giuseppe Morgia, Salvatore Privitera
    Studysummary The abstract discusses that Serenoa repens, a commonly used phytotherapeutic agent, may play a crucial role as an alternative or complementary treatment for lower urinary tract symptoms in patients with benign prostatic hyperplasia, particularly those with mild-to-moderate disease severity.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on sciencedirect.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. What Do We Know About Phytotherapy of Benign Prostatic Hyperplasia? Life Sciences · 2015
    2. Acute Liver Damage Due to Serenoa Repens: A Case Report British Journal of Clinical Pharmacology · 2010
    3. Comparison of Finasteride, a 5α Reductase Inhibitor, and Various Commercial Plant Extracts in In Vitro and In Vivo 5α Reductase Inhibition The Prostate · 1993